Unlock instant, AI-driven research and patent intelligence for your innovation.

Antiviral partial film forming gel composition

A gel composition and the technology of the composition are applied in the directions of antiviral agents, active ingredients of heterocyclic compounds, drug delivery, etc., which can solve the problems of membrane rupture, disappearance, and shedding, and achieve good biocompatibility and easy availability of raw materials. , the effect of good flexibility

Inactive Publication Date: 2008-06-04
SHANGHAI INST OF PHARMA IND CO LTD
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, we found that the local film-forming gel composition made of monoglyceryl laurate as a cross-linking agent, although the flexibility of the film is enhanced, but the time to adhere to the skin or mucous membrane is relatively short, such as in the oral cavity. The film formed on the mucous membrane is easily eroded / dissolved by body fluids or saliva, causing the film to rupture and fall off prematurely, resulting in faster disappearance
[0007] Therefore, as adopting the technology of above-mentioned existing film-forming gel composition to prepare antiviral local film-forming gel composition, then the medicament wherein and affected part keep time is shorter, influences curative effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antiviral partial film forming gel composition
  • Antiviral partial film forming gel composition
  • Antiviral partial film forming gel composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1~14

[0038] Examples 1-14 and comparative examples *

[0039] Dissolve the antiviral drugs (without the drug in the control example) and the esterification agent in each dosage of Examples 1-14 and the control example in Table 1 in a dissolvable solvent, and slowly add the hydroxyl group under stirring. After the propyl cellulose is completely dissolved / swelled, continue to stir to form a uniform gel; then add the cross-linking agent (if necessary, add enhancers and additives), continue to stir to make it completely uniform; supplement the remaining amount of solvent, 100 grams of antiviral local film-forming gel composition and drug-free control film-forming gel composition were prepared by making it reach the prescribed amount, stirring evenly, and degassing.

[0040] Table 1

[0041]

[0042]

[0043] "*" indicates that the added antiviral drug is ganciclovir, "#" indicates that the added antiviral drug is penciclovir, and the antiviral drug added in the remaining examples is a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an antivirus local film-forming gel compound and the application of the gel compound, comprising the following weight-percentage components: 0.5 to 7 percent of hydroxyalkyl fibrin, 1 to 10 percent of esterifying agent, 0.5 to 5 percent of crosslinking agent, 0 to 5 percent of intensifier, 75 to 90 percent of menstruum and 0.1 to 5 percent of antivirus medicines; wherein, the crosslinking agent is a saturated fat polyol or alkyd which has the chemical general equation is CnH2n+2-m-l (OH) m (COOH) l, and n, m and l are whole numbers and n is more than or equal to m which is more than or equal to 2, and l is more than or equal to 0, and m plus 1 is from 4 to 8 and n plus 1 is from 4 to 8. When the antivirus local film-forming gel compound of the invention is spread onto skin or a mucosa surface, a smooth, tough, wear-resistant and waterproof protection film can be formed. Compared with the existing various antivirus local agents, the film formed by the gel compound is characterized in that the preservation time is long and the medicine effect can be released for a long time. The formed gel film can be preserved for more than 7 hours on the skin surface and can be preserved for about 5 hours on the surface of the oral mucosa, with better anti local virus-infection of both skin and mucosa.

Description

Technical field [0001] The invention relates to an antiviral local film-forming gel composition for treating local viral infectious diseases of the skin and mucous membranes. Background technique [0002] Local viral infections of the skin and mucous membranes are usually caused by human papillomavirus, herpes virus, etc., such as flat warts, common warts, plantar warts, condyloma acuminatum, herpes zoster and herpetic stomatitis. Aciclovir, Penciclovir and Ganciclovir, etc., are deoxyguanosine broad-spectrum antiviral drugs, which are widely used clinically to treat various viral infectious diseases The commonly used external dosage forms include ointments, creams, gels, etc. When such preparations are applied to the surface of skin tissues, these agents are easy to use due to friction with clothes or the outside world, as well as the secretion of body fluids and perspiration. It is wiped off or eluted, usually on the skin surface for a short time, resulting in a short retention...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K9/70A61K47/38A61K47/14A61K31/522A61P31/12A61P31/20A61P31/22
Inventor 马晋隆陈志明史家骏
Owner SHANGHAI INST OF PHARMA IND CO LTD